Insanitary Conditions at Compounding Facilities Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 6, 2020
November 6, 2020
6f8ff3c8-2f4a-49e4-a919-fc3c6b83579d
Related Documents
Requests for Reconsideration at the Division Level Under GDUFA
Guidance DocumentOctober 16, 2024Center for Drug Evaluation and Research
Eosinophilic Esophagitis: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentSeptember 15, 2020Center for Drug Evaluation and Research
Compounding and Repackaging of Radiopharmaceuticals By Outsourcing Facilities Guidance for Industry
Guidance DocumentSeptember 26, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox